Founded in 2007, Bora is the largest pharmaceutical manufacturer in Taiwan with well-connected global distribution to supply more than 100 countries around the world. Bora's services include outsourced R&D and toll manufacturing.

In January 2024, Bora acquired Upsher-Smith Laboratories, a US generics manufacturer, for $210 million. This deal completed Bora's capabilities to serve customers throughout the value chain, covering the entire US market.